reglab/statecodes huggingface dataset:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Section 540-X-10-.05 - Standards For Office-Based Procedures - Minimal Sedation

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Equipment and
			 supplies: Oral airway positive pressure ventilation device, epinephrine, and
			 atropine should be available.
(2)
			 Training required: The physician is expected to be knowledgeable in proper drug
			 dosages, recognition and management of toxicity or hypersensitivity to local
			 anesthetic and other drugs. It is recommended that the physician be currently
			 trained in Basic Cardiac Life Support (BCLS).
(3) Assistance of other personnel: Anesthesia
			 should be administered only by licensed, qualified and competent practitioners
			 who have training and experience appropriate to the level of anesthesia
			 administered and function in accordance with their scope of practice.
			 Practitioners must have documented competence and training to administer local
			 anesthesia with sedation and to assist in any support or resuscitation measures
			 as required. Scrub or Circulating nurse(s) and/or assistant(s) must be trained
			 in their specific job skills as determined by the supervising physician.
Authors:
Alabama Board of Medical Examiners
ad hoc
Committee: Arthur F. Toole, III, M.D.; Jorge A. Alsip,
				M.D.; James G. Chambers, III, M.D.; Craig H. Christopher, M.D.; Alcus Ray
				Hudson, M.D.; Pamela D. Varner, M.D.; James E. West, M.D.; and Task Force
				Sub-Committee: Jeff Plagenhoef, M.D.; Eric Crum, M.D.; Dan J. Coyle, Jr., M.D.;
				Gary Monheit, M.D.; Robert Hurlbutt, IV, M.D.; C. Paul Perry, M.D.; W. Guinn
				Paulk, M.D.; Mark McIlwain, D.M.D., M.D.; Jerald Clanton, D.M.D., M.D.; Patrick
				J. Budny, M.D.; James W. Northington, M.D.; David Franco, M.D.; Thomas E.
				Moody, M.D.
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Section 540-X-10-.09 - Recovery Area And Assessment For Discharge With Moderate And Deep Sedation/General Anesthesia - Monitoring Requirement

Current through Register Vol. 42, No. 9, June 28, 2024
Monitoring in the recovery area should be performed by a
dedicated
person, trained in their specific job skills as
				determined by the supervising physician, and must include pulse oximetry and
				non-invasive blood pressure measurement. The patient must be assessed
				periodically for level of consciousness, pain relief, or any untoward
				complication. Each patient should meet discharge criteria as established by the
				practice, prior to leaving the facility. Documented recovery from anesthesia
				should include the following:
1) vital
			 signs and oxygen saturation stable within acceptable limits;
2) no more than minimal nausea, vomiting or
			 dizziness; and
3) sufficient time
			 (up to 2 hours) should have elapsed following the last administration of
			 reversal agents to ensure the patient does not become sedated after reversal
			 effects have worn off. The patient should be given appropriate discharge
			 instructions and discharge under the care of a responsible third party after
			 meeting discharge criteria. Discharge instructions should include:
1) the procedure performed;
2) information about potential complications;
3) telephone numbers to be used by
			 the patient to discuss complications or questions that may arise;
4) instructions for medications prescribed
			 and pain management;
5) information
			 regarding the follow-up visit date, time and location; and
6) designated treatment facility in the event
			 of an emergency (office-based physician's number, not the emergency room).
Authors:
Alabama Board of Medical Examiners
ad hoc
Committee: Arthur F. Toole, III, M.D.; Jorge A. Alsip,
				M.D.; James G. Chambers, III, M.D.; Craig H. Christopher, M.D.; Alcus Ray
				Hudson, M.D.; Pamela D. Varner, M.D.; James E. West, M.D.; and Task Force
				Sub-Committee: Jeff Plagenhoef, M.D.; Eric Crum, M.D.; Dan J. Coyle, Jr., M.D.;
				Gary Monheit, M.D.; Robert Hurlbutt, IV, M.D.; C. Paul Perry, M.D.; W. Guinn
				Paulk, M.D.; Mark McIlwain, D.M.D., M.D.; Jerald Clanton, D.M.D., M.D.; Patrick
				J. Budny, M.D.; James W. Northington, M.D.; David Franco, M.D.; Thomas E.
				Moody, M.D.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Section 540-X-10-.10 - Tumescent Liposuction And Similarly Related Procedures

Current through Register Vol. 42, No. 9, June 28, 2024
(1) In the performance of liposuction when
			 infiltration methods such as the tumescent technique are used, they should be
			 regarded as regional or systemic anesthesia because of the potential for
			 systemic toxic effects.
(2) When
			 infiltration methods such as the tumescent technique are used in the
			 performance of liposuction, the Standards for Office Based Procedures - General
			 and Regional Anesthesia stated in Rule
			 540-X-10-.08 shall be met,
			 including the physician registration requirement, the equipment and supplies
			 requirement, the training requirement and the assistance of other personnel
			 requirement.
(3) When infiltration
			 methods such as the tumescent technique are used in the performance of
			 liposuction, the monitoring requirement found in Rule
			 540-X-10-.09, Recovery Area and
			 Assessment for Discharge with Moderate and Deep Sedation/General Anesthesia -
			 Monitoring Requirement, must be met.
Authors:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Section 540-X-10-.12 - Registration Of Office-Based Surgery/Procedures Physician

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Prior to performing any office-based
			 surgery/procedures as defined in this rule, registration is required of any
			 physician who is licensed to practice medicine in Alabama, who maintains a
			 practice location in Alabama, and who performs or offers to perform the
			 following:
(a) Any office-based
			 surgery/procedure which requires moderate sedation, deep sedation or general
			 anesthesia, as defined in these rules, or
(b) Liposuction when infiltration methods
			 such as the tumescent technique are used, or
(c) Any procedure in which propofol is
			 administered, given or used.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Section 540-X-10-.13 - Penalty

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A physician may
			 be guilty of unprofessional conduct within the meaning of
Code of
			 Ala. 1975
, §
								34-24-360(2) if
			 he fails to comply with the requirements of these rules concerning any of the
			 following:
(a) Standards for office-based
			 procedures for moderate sedation/analgesia or general/regional
			 anesthesia;
(b)
			 Reporting;
(c) Emergency care and
			 transfer;
(d)
			 Registration.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Appendix B - STANDARDS OF THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Current through Register Vol. 42, No. 9, June 28, 2024
Click to view
				image
Click to
				view image
Click to
				view image
Click to
				view image
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Appendix C - GUIDELINES FOR OFFICE-BASED ANESTHESIA

Current through Register Vol. 42, No. 9, June 28, 2024
Click to view
				image
Click to
				view image
Click to
				view image
Click to
				view image
Click to
				view image
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Appendix D - OFFICE-BASED SURGERY/PROCEDURES PHYSICIAN REGISTRATION FORM

Current through Register Vol. 42, No. 9, June 28, 2024
Click to view
				image
Click to view
				image
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-10 - OFFICE-BASED SURGERY › Appendix E - AMERICAN ASSOCIATION FOR ACCREDITATION OF AMBULATORY FACILITIES, INC., GUIDELINES FOR STERILIZATION

Current through Register Vol. 42, No. 9, June 28, 2024
Click to
				view image
Click to
				view image
Click to
				view image
Authors:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.01 - Purpose

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The use of
			 lasers/pulsed light devices, or any energy source, chemical, or other modality
			 that affects living tissue (when referring to the skin, anything below the
			 stratum corneum), whether applied for surgical, therapeutic, or cosmetic
			 purposes, is the practice of medicine.
(2) The purpose of these rules is to provide
			 guidelines for the use of these devices for ablative and non-ablative treatment
			 by physicians. Nothing in these rules shall be construed to relieve the
			 supervising physician of the professional or legal responsibility for the care
			 and treatment of the physician's patients.
(3) These rules shall not apply to the
			 following:
(a) Any person licensed to practice
			 chiropractic if the laser/pulsed light device, energy source, chemical or other
			 modality that affects living tissue is used exclusively for the practice of
			 chiropractic;
(b) Any person
			 licensed to practice dentistry if the laser/ pulsed light device, energy
			 source, chemical or other modality that affects living tissue is used
			 exclusively for the practice of dentistry;
(c) Any person licensed to practice
			 occupational therapy if the laser/pulsed light device, energy source, chemical
			 or other modality that affects living tissue is used exclusively for the
			 practice of occupational therapy;
(d) Any person licensed to practice optometry
			 if the laser/ pulsed light device, energy source, chemical or other modality
			 that affects living tissue is used exclusively for the practice of
			 optometry;
(e) Any person licensed
			 to practice physical therapy if the laser/pulsed light device, energy source,
			 chemical or other modality that affects living tissue is used exclusively for
			 the practice of physical therapy.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.04 - Delegation And Supervision

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A
			 physician may delegate the performance of non-ablative treatments as defined in
			 these rules through the use of written protocols to a properly trained Level 1
			 or 2 Delegate.
(2) A delegating
			 physician shall supervise the performance of all non-ablative treatments
			 delegated to a Level 1 or 2 Delegate. This supervision must include:
(a) Ensuring that patients are adequately
			 informed and, prior to treatment, have signed consent forms that outline Risks,
			 Benefits, Alternatives, and Complications, including the disclosure of
			 reasonably foreseeable side effects and complications that may result from the
			 non-ablative treatment, as well as the name of the device and the
			 procedure;
(b) Responsibility for
			 the formulation or approval of a written protocol that meets the requirements
			 of these rules and responsibility for any patient-specific deviation from the
			 protocol;
(c) Substantive review
			 and authorization, at least annually, of the written protocol and any
			 patient-specific deviations from the protocol regarding care provided to a
			 patient under the protocol on a schedule defined in the written
			 protocol;
(d) Ensuring that any
			 Level 1 or 2 Delegate has read and signed the facility's policies and
			 procedures, written protocols for delegation, and these rules regarding the
			 safe use of non-ablative devices;
(e) Prompt receipt of information from the
			 Level 1 or 2 Delegate concerning any problem or complication encountered with
			 any treatment;
(f) On-site or
			 locally remote supervision for non-ablative treatments performed by Level 1 and
			 2 Delegates consistent with these rules, the training and experience of the
			 delegate performing the procedure, and the risk of harm to the
			 patient;
(g) Personal evaluation
			 and care for complications that arise; and
(h) Evaluation of the technical skills of the
			 Level 1 or 2 Delegate performing non-ablative treatments on an ongoing basis by
			 formally documenting and reviewing at least annually the Level 1 or 2
			 Delegate's ability to perform the following:
1. To properly operate the devices and
			 provide safe and effective care; and
2. To respond appropriately to concerns,
			 complaints, and complications and untoward effects of the procedures.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.05 - Written Protocols

Current through Register Vol. 42, No. 9, June 28, 2024
Written protocols for the purpose of this section shall mean
				physician's order, standing delegation order, standing medical order, or other
				written order that is maintained on site. A written protocol must be provided
				to the Board upon request and must provide, at a minimum, the following:
(1) A statement identifying the individual
			 physician authorized to utilize the specified device and responsible for the
			 delegation of the performance of the specified procedure, including proof of
			 the physician's training in accordance with these rules;
(2) A statement of the activities, decision
			 criteria, and plan the Level 1 or 2 Delegate shall follow when performing
			 delegated procedures;
(3) Selection
			 criteria to screen patients for the appropriateness of non-ablative
			 treatments;
(4) Identification of
			 devices and settings to be used for patients who meet selection
			 criteria;
(5) Methods by which the
			 specified device is to be operated;
(6) A description of appropriate care and
			 follow-up for common complications, serious injury, or emergencies as a result
			 of the non-ablative treatment;
(7)
			 Procedures for obtaining proper consent forms signed by the patient or legal
			 guardian;
(8) Instructions for
			 maintaining a patient's chart, which should include, at a minimum, the patient
			 intake form, the executed informed consent, the treatment sheet and progress
			 notes, and before and after instructions;
(9) Instructions for documentation of a
			 patient's treatment, decisions made, and a plan for communication or feedback
			 to the authorizing physician concerning specific decisions made. Documentation
			 shall be recorded within a reasonable time after each procedure and may be
			 performed on the patient's record or medical chart; and
(10) Instructions to contact the supervising
			 physician immediately if complications or complaints from the patient
			 arise.
(11) Written protocols
			 should be signed by both the supervising physician and the corresponding Legal
			 1 or 2 Delegate.
Original Rule .05, Supervision, was repealed and rule .06 was
				  renumbered .05 per certification published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.06 - Initial Training Requirements For Physicians And Delegates

Current through Register Vol. 42, No. 9, June 28, 2024
Physicians and delegates involved in the use of lasers/pulsed
				light devices, or any energy source, chemical, or other modality that affects
				living tissue, whether applied for surgical, therapeutic, or cosmetic purposes,
				must meet the following training requirements before utilizing a device:
(1) A physician must complete thirty (30)
			 hours of training. A Level 1 or 2 Delegate must complete forty (40) hours of
			 training.
(2) Appropriate training
			 for the use of any device covered by this Chapter shall include the following
			 topics:
(a) Theory and physics of laser and
			 light/energy-based devices and procedures, including their effect on living
			 tissue, tissue interaction, clinical applications, and pre/post-treatment
			 care;
(b) Education of skin anatomy
			 and physiology, concerns, conditions, and diseases, including cancer, of the
			 skin, skin type and color, chromophores, targets, general care for the skin,
			 and recognition, management, and reporting of side effects and
			 complications;
(c) Eight (8) hours
			 of LLBD safety training, and
(d)
			 Two (2) hours of training on the Board's rules and regulations, including this
			 Chapter.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.07 - Procedure And Device Requirements For Physicians And Delegates

Current through Register Vol. 42, No. 9, June 28, 2024
Physicians and delegates involved in the use of LLBDs must
				complete a minimum number of procedure/device-specific training hours, a
				minimum number of observed procedures, a minimum number of supervised
				procedures, and a minimum number of cases under supervision as set forth
				below.
(1) Ablative Laser Skin
			 Resurfacing:
(a) Prior to performing
			 procedures with any category of LLBD, physicians must complete eight (8) hours
			 of training in the device or device category, unless the physician received
			 training on the device in residency, in which case only four (4) hours of
			 training are required.
(b) Level 1
			 and 2 Delegates shall not perform these procedures.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.08 - Remote Practice Site

Current through Register Vol. 42, No. 9, June 28, 2024
(1) For
			 the purposes of the rules in this Chapter, a remote practice site is a practice
			 site at which a Level 1 Delegate may, if authorized by a written job
			 description or collaborative protocol, use LLBDs for non-ablative procedures
			 under locally remote supervision.
(2) A Level 2 Delegate shall not use LLBDs at
			 a remote practice site without their supervising physician on-site. Locally
			 remote supervision is not allowed for a Level 2 Delegate.
(3) The physician shall examine the patient,
			 establish a treatment plan, perform informed consent of the patient, and sign
			 the patient chart prior to a Level 1 Delegate performing the first non-ablative
			 treatment of a patient for a particular disease or condition at a remote
			 practice site. Subsequent non-ablative treatments which are a continuation of a
			 treatment plan documented in the patient's chart may be performed by the Level
			 1 Delegate at a remote practice site without examination of the patient by the
			 physician before each treatment. If any changes are made to the treatment plan
			 or the treatment plan ends, the physician must re-examine the patient prior to
			 any updated treatment being performed.
Previous Rule .09 was renumbered .08 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.09 - Alternate Physicians

Current through Register Vol. 42, No. 9, June 28, 2024
(1) If a
			 delegating physician will be unavailable to supervise a Level 1 or 2 Delegate
			 as required by these rules, arrangements shall be made for an alternate
			 physician to provide that supervision.
(2) An alternate physician must have the same
			 training in performance of non-ablative treatments as the primary supervising
			 physician.
(3) Any alternate
			 physician providing supervision shall affirm in writing to the Board of Medical
			 Examiners that he or she is familiar with the protocols or standing delegation
			 orders in use at the site, will be accountable for adequately supervising care
			 provided pursuant to those protocols or standing delegation orders, and has the
			 same training in performance of non-ablative treatments as the primary
			 supervising physician.
Previous Rule .10 was renumbered .09 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.10 - Quality Assurance

Current through Register Vol. 42, No. 9, June 28, 2024
The physician must ensure that there is a quality assurance
				program for the facility where non-ablative procedures are performed for the
				purpose of continuously improving the selection and treatment of patients. An
				appropriate quality assurance program shall consist of the elements listed in
				paragraphs (1) -(5) of this section.
(1) A mechanism to identify complications and
			 untoward effects of treatment and to determine their cause.
(2) A mechanism to review the adherence of
			 delegates to standing delegation orders, standing medical orders, and written
			 protocols.
(3) A mechanism to
			 monitor the quality of non-ablative treatments.
(4) A mechanism by which the findings of the
			 quality assurance program are reviewed and incorporated into future standing
			 delegation orders, standing medical orders, protocols, and supervising
			 responsibility.
(5) Ongoing
			 training to improve the quality and performance of delegates.
Previous Rule .11 was renumbered .10 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.11 - Equipment Safety

Current through Register Vol. 42, No. 9, June 28, 2024
All equipment used for the purposes stated in this Chapter must
				be inspected, calibrated, and certified as safe to use according to the
				manufacturer's specifications.
Previous Rule .12 was renumbered .11 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.12 - Safe Use of Lasers

Current through Register Vol. 42, No. 9, June 28, 2024
In addition to the requirements of these rules, all physicians
				and delegates who use or operate lasers must comply with any regulations,
				standards, directives and guidelines for laser safety and use issued by the
				Occupational Safety and Health Administration, United States Department of
				Labor.
Previous Rule .13 was renumbered .12 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.13 - Registration Of Physicians Using Lasers In The Practice Of Medicine

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Every physician
			 who proposes to perform any LLBD procedure in Alabama under these rules shall
			 register with the Board prior to performing any procedure.
(2) Registration shall be accomplished on a
			 form provided by the Board.
(3)
			 After initially registering, it shall be the obligation of the registrant to
			 notify the Board in writing of any change or addition of facility location
			 where LLBD procedures occur or are offered for use.
(4) Beginning January 2024, annual
			 registration as a provider of LLBD procedures shall be required and shall be
			 accomplished by electronic means.
(5) Annual registration as an LLBD provider
			 shall be due by January 31 of each year.
Previous Rule .14 was renumbered .13 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.14 - Reporting Requirement For Adverse Events

Current through Register Vol. 42, No. 9, June 28, 2024
Every physician who performs or supervises the performance of a
				procedure covered under these rules shall report to the Board within three (3)
				business days the occurrence of all events related to a procedure that resulted
				in an emergency transfer of a patient to a hospital, unscheduled
				hospitalization related to the procedure, third-degree dermal injury, or
				death.
Previous Rule .15 was renumbered .14 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.15 - Effective Date

Current through Register Vol. 42, No. 9, June 28, 2024
The deadline for compliance with the provisions of this section
				will be one year following the final adoption of this rule.
Previous Rule .16 was renumbered .15 per certification
				  published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Section 540-X-11-.16 - Continuing Education And Minimum Annual Procedures Required

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Level 1 and 2
			 Delegates must complete a minimum number of hours of continuing LLBD education
			 and a minimum number of procedures to continue performing LLBD procedures under
			 these guidelines. Physicians are exempt from continued LLBD education and an
			 annual minimum number of procedures but must maintain proper training on any
			 procedure or device a Level 1 or 2 Delegate is allowed to utilize. If a
			 delegate fails to meet these requirements, he or she must complete the initial
			 training and procedure-specific training set forth in these
			 guidelines.
(2) Level 1 Delegates
			 must annually complete a minimum of four (4) hours of continuing LLBD
			 education, and Level 2 Delegates must annually complete a minimum of six (6)
			 hours of continuing LLBD education.
(3) Continuing LLBD education may include AMA
			 PRA Category 1 CME hours, LLBD-specific medical conference hours, online study
			 and courses, and self-study through online webinars, lectures, CME courses, and
			 hours lectured by a physician.
(4)
			 Continuing LLBD education obtained may be general for all LLBD procedures and
			 not specific to every procedure performed. Continuing education should include
			 training on LLBD theory and physics; skin anatomy and conditions/diseases; LLBD
			 safety; treatment of conditions; recognition, management, and reporting of side
			 effects and complications; and overall use of LLBD procedures to treat
			 patients.
(5) Level 1 Delegates
			 must complete a minimum of ten (10) total LLBD procedures per year, and Level 2
			 Delegates must complete a minimum of thirty (30) total LLBD procedures per
			 year.
(6) Level 1 Delegates must
			 complete a minimum of ten (10) procedures in each procedure category they
			 practice within, and Level 2 Delegates must complete a minimum of thirty (30)
			 procedures in each procedure category they practice within.
Previous Rule .16 was renumbered .15 and replaced with new
				  rule .16 per certification published May 31, 2023; effective July 15,
				  2023.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-50,
				  34-24-51,
				  34-24-53.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Appendix A - INITIAL SURVEY OF FOREIGN MEDICAL SCHOOLS (REPEALED)

Current through Register Vol. 42, No. 9, June 28, 2024
Authors:
Statutory Authority:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Appendix B - DESCRIPTIVE DATA ON A FOREIGN MEDICAL SCHOOL (REPEALED)

Current through Register Vol. 42, No. 9, June 28, 2024
Authors:
Statutory Authority:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Appendix C - STANDARDS FOR APPROVAL OF FOREIGN MEDICAL SCHOOLS (REPEALED)

Current through Register Vol. 42, No. 9, June 28, 2024
Authors:
Statutory Authority:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-11 - GUIDELINES FOR THE USE OF LASERS AND OTHER MODALITIES AFFECTING LIVING TISSUE › Appendix D - PROCEDURES FOR THE SITE VISIT AND THE SITE VISIT TEAM (REPEALED)

Current through Register Vol. 42, No. 9, June 28, 2024
Authors:
Statutory Authority:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.01 - Definitions

Current through Register Vol. 42, No. 9, June 28, 2024
The following definitions shall apply to the rules in this
				chapter:
(1) Administer - The direct
			 application of a controlled substance, whether by injection, inhalation,
			 ingestion, or any other means, to the body of a patient by any of the
			 following:
(a) A supervising physician, or, in
			 his or her presence, his or her authorized agent.
(b) An assistant to physician.
(c) The patient at the direction and in the
			 presence of the supervising physician or assistant to physician.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.02 - General Requirements

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The
			 Board is the certifying board which may issue to and renew, deny, restrict,
			 limit, suspend, or revoke a QACSC of an assistant to physician.
(2) Beginning the calendar year 2010, QACSCs
			 may be issued by the Board to Physician Assistants (P.A.s).
(3) Although the Board recognizes two
			 categories of assistants to physicians, only a person licensed and registered
			 by the Board as a Physician Assistant (P.A.) may be issued a QACSC.
(4) A P.A. who prescribes, administers, or
			 authorizes for administration any controlled substance within Alabama or who
			 proposes to engage in the prescribing, administering, or authorizing for
			 administration any controlled substance within Alabama shall obtain, annually,
			 a QACSC for each registration of the P.A. by the Board to perform medical
			 services under the supervision of a physician.
(5) A P.A. who prescribes, administers, or
			 authorizes for administration, or who proposes to engage in the prescribing,
			 administering, or authorizing for administration any controlled substance
			 within Alabama shall obtain the appropriate registration or registrations
			 issued by the United States Drug Enforcement Administration.
(6) A P.A. who applies for a Qualified
			 Alabama Controlled Substances Certificate shall provide the Board with the DEA
			 registration number authorizing his or her prescribing of controlled substances
			 in Alabama at the time of application, or, if no such registration has been
			 issued, shall provide the Board with the DEA registration number as soon as it
			 is issued. Each P.A. who is issued a Qualified Alabama Controlled Substances
			 Certificate shall provide a copy of the DEA registration certificate to the
			 Board immediately upon renewal of the registration.
(7) The Board of Medical Examiners may
			 decline to consider an application when the P.A. or the supervising physician
			 is under investigation for a potential violation of the
Code of Ala
			 1975
, Sections
			 20-2-1, et. seq., or 34-24-50, et.
			 seq., or any rule of the Alabama Board of Medical Examiners or Medical
			 Licensure Commission of Alabama.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										20-2-60, et. seq; Act
				  2009-489.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.03 - Requirements For The Issuance Of A Qualified Alabama Controlled Substances Registration Certificate (QACSC)

Current through Register Vol. 42, No. 9, June 28, 2024
To qualify for a QACSC, an individual must meet the following
				requirements:
(1) Be a Physician
			 Assistant (P.A.) who holds a current and unrestricted license issued by the
			 Board and who is registered by the Board to perform medical services under the
			 supervision of a physician who holds and a maintains a valid, current and
			 unrestricted Alabama Controlled Substances Registration Certificate
			 (ACSC);
(2) Be a P.A. who is
			 practicing with appropriate physician supervision and in accordance with all
			 statutes and rules governing P.A.s;
(3) Submit proof of successful completion of
			 a course or courses (AMA PRA Category 1TM) approved by the Board which includes
			 eight (8) hours of instruction regarding the prescribing of controlled
			 substances and four (4) hours of advanced pharmacology and prescribing trends
			 relating to controlled substances within one (1) year preceding the filing of
			 an application for a QACSC.
(4)
			 Provide accurate and complete documentation of a minimum of twelve (12) months
			 of active clinical practice pursuant to one or more registration agreements
			 approved by the Alabama Board of Medical Examiners following National
			 Commission on Certification of Physician Assistants (NCCPA) certification.
			 Interim approval of a supervised practice shall not be considered or used to
			 meet this requirement.
(a) In lieu of
			 completing twelve (12) months of active clinical practice in the state of
			 Alabama, the applicant must have at least three (3) years of active clinical
			 practice under the supervision of a physician as a license P.A. in any U.S.
			 state or territory and meet the following requirements:
1. Applicant must have held a DEA
			 registration for at least one (1) year in any state;
2. Has never had his or her license to
			 practice as a P.A. subject to discipline by a licensing agency in any state,
			 federal, or foreign jurisdiction, excluding any action related to the
			 non-payment of fees related to a license;
3. Has never had a controlled substance
			 license or permit suspended or revoked by a state or the U.S. Drug Enforcement
			 Administration; and
4. Is not
			 currently under investigation by a licensing agency or law enforcement
			 authority in any state, federal, or foreign jurisdiction.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.03.01 - Application for a Qualified Alabama Controlled Substances Registration Certificate (QACSC)

Current through Register Vol. 42, No. 9, June 28, 2024
An applicant for a Qualified Alabama Controlled Substances
				Certificate shall disclose whether:
(1) Applicant's privilege for prescribing
			 controlled substances has ever been suspended, restricted, voluntarily
			 surrendered while under investigation, revoked, or disciplined in any manner in
			 any state or U.S. territory.
(2)
			 Applicant has ever been convicted of any state or federal crime relating to any
			 controlled substance.
(3) Any
			 Federal Drug Enforcement Administration registration ever held by applicant has
			 ever been suspended, restricted, revoked, or voluntarily surrendered while
			 under investigation.
(4)
			 Applicant's staff privileges at any hospitals have ever been suspended,
			 restricted, revoked, or disciplined in any manner for any reason related to the
			 prescribing or administering of controlled substances.
(5) Applicant is currently engaged in the
			 excessive use of alcohol, controlled substances, or the use of illegal drugs,
			 or receiving any therapy or treatment for alcohol or drug use, sexual boundary
			 issues, or mental health issues.
(a) If
			 applicant is an anonymous participant in the Alabama Professionals Health
			 Program and is in compliance with their assistance agreement, they may answer
			 "No" to this question. Such answer for this purpose will not be deemed upon
			 certification as providing false information to the Alabama Board of Medical
			 Examiners.
(b) The term "currently"
			 as it is used in paragraph (5) above does not mean on the day of, or even in
			 the weeks or months preceding the completion of the application. Rather, it
			 means recently enough so that the condition referred to may have an ongoing
			 impact on one's functioning as an assistant to physicians within the last two
			 years.
(c) Applicant shall initial
			 certifying an understanding of a statement of the duty as a licensee to address
			 any such condition, which states as follows:
IMPORTANT: The Board recognizes that licensees encounter health
				conditions, including those involving mental health and substance use
				disorders, just as their patients and other health care providers do. The Board
				expects its licensees to address their health concerns and ensure patient
				safety. Options include anonymously self referring to the Alabama Professionals
				Health Program (334-954-2596), a physician advocacy organization dedicated to
				improving the health and wellness of medical professionals in a confidential
				manner. The failure to adequately address a health condition, where the
				licensee is unable to practice medicine with reasonable skill and safety to
				patients, can result in the Board taking action against the license to practice
				medicine.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.04 - Issuance Of A Qualified Alabama Controlled Substances Registration Certificate (QACSC)

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The Board
			 may issue a QACSC to a P.A. when all of the requirements for issuance have been
			 met.
(2) Every QACSC issued shall
			 have a unique QACSC number which identifies the particular applicant as a P.A.
			 with a valid QACSC.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										20-2-60,
et
.
seq
.; Act
				  2009-489.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.05 - Renewal Of A Qualified Alabama Controlled Substances Registration Certificate (QACSC)

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Renewal of
			 a QACSC shall be annually on or before January 1st
			 of each year. An application for annual renewal of a QACSC shall be received by
			 the Board on or before December 31st and shall be
			 accompanied by the required QACSC renewal fee.
(2) The Board shall not renew the QACSC of
			 any P.A. when an administrative fine has been assessed by the Board until such
			 fine is paid in full. In the event that the fine is subsequently reduced or set
			 aside on judicial review, the P.A. shall be entitled to a prompt refund of the
			 amount of the fine, but shall not be entitled to interest thereon.
(3) As a requirement for renewing a QACSC, a
			 P.A. shall obtain, every two years, four (4) AMA PRA Category 1
			 creditsTM or equivalent through a Board approved
			 course or courses regarding the prescribing of controlled substances.
(4) Before renewing a Qualified Alabama
			 Controlled Substances Certificate, the applicant shall have a current
			 registration to access the Controlled Substances Prescription Database
			 established and maintained by the Alabama Department of Public
			 Health.
(5) Before renewing a
			 Qualified Alabama Controlled Substances Certificate, an applicant shall have a
			 current and appropriate registration issued by the United States Drug
			 Enforcement Administration.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										20-2-60,
et
.
seq
.; Act
				  2009-489.
The amended
				version of this section by
				Alabama
				Administrative Monthly Volume XXXVI, Issue No. 06, March 30,
				2018, file. 2/27/2018 is not
				yet available.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-12 - QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) › Section 540-X-12-.05.01 - Renewal of a Qualified Alabama Controlled Substances Registration Certificate (QACSC) - Required Disclosures

Current through Register Vol. 42, No. 9, June 28, 2024
(1)
			 The applicant shall disclose whether:
(a)
			 Applicant's privilege for dispensing or prescribing controlled substances has
			 ever been suspended, restricted, voluntarily surrendered while under
			 investigation, revoked, or disciplined in any manner in any state or U.S.
			 territory.
(b) Applicant has ever
			 been convicted of any state or federal crime relating to any controlled
			 substance.
(c) Any Federal Drug
			 Enforcement Administration registration ever held by applicant has ever been
			 suspended, restricted, revoked, or voluntarily surrendered while under
			 investigation.
(d) Applicant's
			 privileges at any hospitals have ever been suspended, restricted, revoked, or
			 disciplined in any manner for any reason related to the prescribing or
			 dispensing of controlled substances.
(e) Applicant is currently engaged in the
			 excessive use of alcohol, controlled substances, or the use of illegal drugs,
			 or receiving any therapy or treatment for alcohol or drug use, sexual boundary
			 issues or mental health issues.
1. If
			 applicant is an anonymous participant in the Alabama Professionals Health
			 Program and is in compliance with their assistance agreement, they may answer
			 "No" to this question. Such answer for this purpose will not be deemed upon
			 certification as providing false information to the Alabama Board of Medical
			 Examiners.
2. The term "currently"
			 as it is used in paragraph (5) above does not mean on the day of, or even in
			 the weeks or months preceding the completion of the application. Rather, it
			 means recently enough so that the condition referred to may have an ongoing
			 impact on one's functioning as an assistant to physicians within the last two
			 years.
3. Applicant shall initial
			 certifying an understanding of a statement of the duty as a licensee to address
			 any such condition, which states as follows:
IMPORTANT: The Board recognizes that licensees encounter health
				conditions, including those involving mental health and substance use
				disorders, just as their patients and other health care providers do. The Board
				expects its licensees to address their health concerns and ensure patient
				safety. Options include anonymously self referring to the Alabama Professionals
				Health Program (334-954-2596), a physician advocacy organization dedicated to
				improving the health and wellness of medical professionals in a confidential
				manner. The failure to adequately address a health condition, where the
				licensee is unable to practice medicine with reasonable skill and safety to
				patients, can result in the Board taking action against the QACSC and/or
				license to practice as a Physician
				Assistant.